Home » Healthcare » Infection Surveillance Solutions Market

Infection Surveillance Solutions Market By Software (On-Premises Software, Web-Based Software); By Services (Product Support & Maintenance Services, Training & Consulting Services, Implementation Services); By End User (Hospitals, Long-Term Care Facilities, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Infection Surveillance Solutions Market Size 2024	USD 703.66 million
Infection Surveillance Solutions Market, CAGR	13.50%
Infection Surveillance Solutions Market Size 2032	USD 1,928.54 million

Market Overview

The Infection Surveillance Solutions Market size was valued at USD 460.00 million in 2018 to USD 703.66 million in 2024 and is anticipated to reach USD 1,928.54 million by 2032, at a CAGR of 13.50 % during the forecast period.

The Infection Surveillance Solutions Market is driven by the increasing incidence of healthcare-associated infections (HAIs), rising regulatory mandates for infection control, and growing awareness regarding patient safety and clinical risk management. Healthcare institutions are adopting advanced surveillance software to enhance real-time monitoring, streamline reporting, and ensure regulatory compliance. The shift toward digitized hospital infrastructure, especially in developed economies, further accelerates the integration of infection surveillance systems. Trends indicate a rising demand for cloud-based solutions, artificial intelligence-powered analytics, and interoperable platforms that support seamless data exchange across healthcare settings. The expansion of telehealth and remote patient monitoring is also contributing to broader adoption, particularly in post-acute care environments. Vendors are focusing on offering customizable, user-friendly interfaces and automated alert systems to improve infection detection efficiency. Strategic partnerships between software providers and healthcare organizations are fostering innovation and expanding product capabilities. Collectively, these factors are transforming infection prevention practices and reinforcing the critical role of surveillance in improving healthcare outcomes.

The Infection Surveillance Solutions Market spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with North America leading due to strong regulatory frameworks and advanced healthcare infrastructure. Europe follows closely, driven by stringent infection control mandates and robust public health systems. Asia Pacific is the fastest-growing region, supported by healthcare digitization and government-led safety initiatives. Latin America and the Middle East show steady progress, fueled by hospital modernization efforts, while Africa holds long-term growth potential amid rising awareness and international health support. Key players include Becton, Dickinson and Company, Cerner Corporation, Wolters Kluwer N.V., Premier Inc., Baxter International, Merative, Ecolab, RLDatix, Epic Systems, bioMérieux SA, Gojo Industries, IBM Watson Health, PointClickCare, and Stanley Healthcare. These companies drive market advancement through AI integration, cloud deployment, and strategic collaborations across healthcare ecosystems.

Market Insights

The Infection Surveillance Solutions Market was valued at USD 703.66 million in 2024 and is projected to reach USD 1,928.54 million by 2032, growing at a CAGR of 13.50%.
Rising incidence of healthcare-associated infections (HAIs) and stricter regulatory mandates are pushing hospitals to adopt real-time digital surveillance platforms.
Cloud-based deployment, AI-powered analytics, and system interoperability are driving demand across healthcare settings, especially in post-acute and long-term care environments.
High implementation costs and data privacy concerns continue to challenge adoption, particularly among mid-sized facilities in developing regions.
North America leads the market with USD 314.95 million in 2024, supported by strong regulatory frameworks and widespread EHR integration.
Asia Pacific is the fastest-growing region with a CAGR of 15.5%, backed by digitization efforts in China, India, and Japan.
Key players include Becton, Dickinson and Company, Cerner Corporation, Wolters Kluwer, Premier Inc., Baxter, Merative, RLDatix, Epic Systems, and IBM Watson Health.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Drivers

Rising Incidence of Healthcare-Associated Infections (HAIs)

The growing prevalence of healthcare-associated infections is a major driver for the Infection Surveillance Solutions Market. HAIs contribute to increased patient morbidity, prolonged hospital stays, and higher healthcare costs. Hospitals are under pressure to adopt surveillance systems that can detect and track infections quickly and accurately. The market is witnessing increased demand from acute care hospitals, surgical centers, and long-term care facilities. Infection tracking tools help reduce transmission and improve patient safety outcomes. Governments and healthcare organizations are reinforcing infection prevention measures. The Infection Surveillance Solutions Market benefits from this focus on patient-centered, technology-enabled healthcare environments.

For instance, Epic Systems integrates infection surveillance modules with hospital electronic health records (EHRs), enabling acute care hospitals to track infection outbreaks in real time and automate compliance reporting, thereby supporting faster interventions and improved patient outcomes.

Stringent Regulatory Guidelines and Compliance Mandates

Regulatory bodies such as the CDC, WHO, and local health authorities have introduced strict guidelines to manage and report infections. These mandates require healthcare providers to implement structured infection control programs and maintain real-time documentation. The Infection Surveillance Solutions Market responds to this demand by offering systems designed to meet regulatory requirements. Automated alert systems and compliance dashboards improve audit readiness and reporting efficiency. Institutions are adopting digital platforms to avoid penalties and improve accreditation outcomes. Regulatory pressure continues to shape investment in surveillance infrastructure. It positions infection surveillance as a critical operational function in healthcare delivery.

For instance, VigiLanz Corporation offers automated alert systems that notify infection prevention teams of potential healthcare-associated infections, supporting compliance with regulatory mandates and improving audit readiness.

Digital Transformation of Healthcare Infrastructure

The ongoing digitalization of healthcare facilities strengthens the growth of the Infection Surveillance Solutions Market. Hospitals are deploying electronic health records (EHR), integrating analytics, and streamlining data flow across departments. These changes make it easier to embed surveillance solutions into existing clinical workflows. Real-time tracking, data visualization, and predictive analytics enhance infection response strategies. Integration with hospital IT systems boosts user adoption and system performance. Cloud-based solutions offer scalability and accessibility across care settings. This digital evolution supports proactive infection control and hospital-wide collaboration.

Growing Emphasis on Patient Safety and Quality of Care

Patient safety remains a top priority for healthcare institutions globally. The Infection Surveillance Solutions Market supports this goal by providing tools that improve clinical awareness and risk mitigation. Hospitals use surveillance systems to identify infection trends, track antibiotic resistance, and manage outbreak response. Automated systems reduce manual errors and provide timely insights to infection control teams. These platforms contribute to better patient outcomes and reduced operational risks. The rising focus on value-based care further fuels demand for reliable surveillance technologies. It establishes infection prevention as an integral part of healthcare quality frameworks.

Market Trends

Adoption of Cloud-Based and Remote Monitoring Platforms

Cloud-based deployment models are gaining traction across healthcare institutions for their scalability, cost-effectiveness, and ease of integration. The Infection Surveillance Solutions Market is shifting toward platforms that support remote access, multi-facility integration, and real-time data sharing. Cloud systems eliminate infrastructure constraints and allow centralized infection tracking across hospitals, clinics, and long-term care facilities. They also reduce IT maintenance overhead and offer faster implementation. This trend supports efficient decision-making and continuity of care. It positions cloud solutions as a preferred option for modern infection surveillance strategies.

For instance, Philips’ eICU program enables critical care teams to remotely monitor ICU patients using advanced analytics, which has been shown to reduce mortality rates and ICU length of stay.

Integration of Artificial Intelligence and Predictive Analytics

Artificial intelligence and machine learning are reshaping the Infection Surveillance Solutions Market by enabling predictive insights and early intervention capabilities. AI-driven platforms analyze large volumes of patient data to identify infection patterns and flag anomalies. These systems improve accuracy in outbreak prediction and antimicrobial resistance detection. Predictive analytics also enhance resource allocation by identifying high-risk patients and areas. It helps healthcare providers intervene proactively, improving infection control outcomes. This integration drives a move toward smarter, more responsive surveillance ecosystems.

Rising Demand for Interoperability and Seamless EHR Integration

Healthcare institutions are prioritizing interoperability to ensure seamless communication across electronic health records, lab systems, and infection control platforms. The Infection Surveillance Solutions Market is responding with tools that can integrate into diverse IT environments without compromising security or performance. Seamless EHR integration improves clinician workflow, reduces duplication, and accelerates response times. Interoperability ensures real-time infection updates are visible across departments. This trend drives adoption among hospitals focused on coordinated care and system-wide efficiency. It also improves the overall usability of surveillance systems.

For instance, Oulu University Hospital in Finland has implemented a 5G-enabled network to enhance communication between its infection surveillance software and clinical systems, supporting rapid data sharing and coordinated care.

Shift Toward Customizable, User-Friendly Interfaces

Hospitals are increasingly choosing infection surveillance platforms with intuitive interfaces and customizable dashboards. The Infection Surveillance Solutions Market reflects this shift by offering configurable workflows, role-based access, and easy-to-interpret visualizations. User-centric design improves compliance, minimizes training needs, and increases system engagement across clinical and administrative staff. Visual analytics simplify infection trend identification and help teams act quickly. Vendors are investing in human-centered design to meet the usability expectations of healthcare workers. This shift enhances long-term adoption and operational effectiveness.

Market Challenges Analysis

High Implementation Costs and Infrastructure Constraints

The high initial investment required for infection surveillance systems remains a significant barrier, particularly for small and mid-sized healthcare facilities. Licensing fees, integration costs, staff training, and IT infrastructure upgrades contribute to the overall expense. Many institutions struggle to allocate budgets for advanced digital platforms, especially in developing regions. The Infection Surveillance Solutions Market faces resistance from providers who rely on traditional manual processes. Limited technical expertise and system interoperability challenges further complicate implementation. These cost-related constraints slow market penetration across resource-limited settings.

Data Privacy Concerns and Regulatory Compliance Risks

Infection surveillance platforms handle sensitive patient information, making data security and regulatory compliance critical concerns. Healthcare providers must ensure adherence to regional data protection laws such as HIPAA, GDPR, or equivalent local regulations. The Infection Surveillance Solutions Market faces scrutiny regarding encryption standards, data storage practices, and user access controls. Cybersecurity threats and unauthorized data access pose reputational and legal risks to healthcare institutions. Providers hesitate to adopt cloud-based systems without clear guarantees of data integrity and secure transmission. These concerns impact trust and delay adoption among cautious end users.

Market Opportunities

Expanding Healthcare Infrastructure in Emerging Markets

Emerging economies are investing heavily in healthcare modernization, creating strong opportunities for infection surveillance solutions. Governments and private entities are building new hospitals and upgrading existing facilities with advanced digital systems. The Infection Surveillance Solutions Market can benefit from this momentum by offering scalable and cost-effective solutions tailored to regional needs. Local partnerships and government-backed health initiatives support adoption. Vendors have a chance to introduce cloud-based or modular platforms that align with varying infrastructure levels. These markets offer long-term potential for growth and innovation.

Rising Demand for AI-Driven and Real-Time Analytics Tools

The growing emphasis on proactive infection control creates demand for tools powered by artificial intelligence and real-time analytics. Hospitals seek predictive systems that help prevent outbreaks and monitor antimicrobial resistance. The Infection Surveillance Solutions Market can capitalize on this need by integrating machine learning algorithms, natural language processing, and automated alert systems. AI-enhanced solutions support faster decision-making and clinical accuracy. Opportunities also exist in integrating surveillance tools with mobile health platforms and telemedicine systems. This convergence of technologies opens new avenues for market expansion across diverse care environments.

Market Segmentation Analysis:

By Product & Services

The Infection Surveillance Solutions Market is segmented into software and services. Software is further categorized into on-premises and web-based platforms. Web-based software holds a significant share due to its flexibility, remote accessibility, and reduced IT burden. On-premises solutions remain relevant in institutions with strict data control policies. Services include product support & maintenance, training & consulting, and implementation services. Implementation services are vital for seamless system integration, while ongoing support ensures operational continuity. These segments collectively drive end-user efficiency and compliance.

For instance, Becton Dickinson & Co. offers comprehensive implementation and training services for its infection surveillance platforms, ensuring healthcare staff are proficient in system use and that integration with existing IT infrastructure is seamless.

By End User

The Infection Surveillance Solutions Market serves hospitals, long-term care facilities, and other end users. Hospitals account for the largest share due to their high patient volumes and complex infection control needs. Long-term care facilities are adopting surveillance systems to manage infection risks among vulnerable populations. Other end users include ambulatory surgical centers and rehabilitation clinics that require scalable solutions. The growing need for infection prevention across various care settings supports demand across all end-user categories. It strengthens the market’s relevance in both acute and non-acute care environments.

For instance, Premier Inc. launched the PINC AI solution specifically for long-term care facilities in June 2022, enabling these centers to monitor infection risks and improve patient safety through automated analytics

Segments:

Software

On-Premises Software
Web-Based Software

Services

Product Support & Maintenance Services
Training & Consulting Services
Implementation Services

Based on End User

Hospitals
Long-Term Care Facilities
Other End Users

Based on Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis

North America

The North America Infection Surveillance Solutions Market size was valued at USD 207.92 million in 2018 to USD 314.95 million in 2024 and is anticipated to reach USD 862.25 million by 2032, at a CAGR of 13.5% during the forecast period. The region holds the largest share of the global market due to widespread adoption of advanced healthcare IT infrastructure and strong regulatory compliance frameworks. Hospitals and long-term care facilities are actively implementing digital surveillance platforms to meet infection control mandates. The presence of major players and ongoing R&D initiatives support innovation and system upgrades. The U.S. leads market demand with high healthcare spending and advanced analytics capabilities. It continues to set benchmarks in infection prevention and electronic surveillance integration.

Europe

The Europe Infection Surveillance Solutions Market size was valued at USD 117.76 million in 2018 to USD 172.94 million in 2024 and is anticipated to reach USD 446.94 million by 2032, at a CAGR of 12.7% during the forecast period. It benefits from stringent healthcare quality standards and a strong public health infrastructure. Countries such as Germany, the UK, and France are deploying automated surveillance tools to reduce healthcare-associated infections. The EU’s emphasis on antimicrobial resistance monitoring and cross-border health data sharing supports adoption. Hospitals are investing in real-time reporting tools and AI-powered analytics. It continues to experience demand growth across both public and private healthcare facilities.

Asia Pacific

The Asia Pacific Infection Surveillance Solutions Market size was valued at USD 75.07 million in 2018 to USD 122.47 million in 2024 and is anticipated to reach USD 386.67 million by 2032, at a CAGR of 15.5% during the forecast period. Rapid healthcare infrastructure development and digital transformation initiatives drive regional growth. Countries such as China, India, and Japan are investing in hospital digitization and patient safety. Government-led infection prevention programs and rising medical tourism also fuel adoption. Cloud-based and mobile-compatible solutions are gaining traction among budget-sensitive institutions. It represents the fastest-growing regional market with expanding private sector participation.

Latin America

The Latin America Infection Surveillance Solutions Market size was valued at USD 25.07 million in 2018 to USD 37.92 million in 2024 and is anticipated to reach USD 95.21 million by 2032, at a CAGR of 12.3% during the forecast period. Demand is growing due to the region’s focus on improving hospital infection control and addressing healthcare inefficiencies. Brazil and Mexico are key contributors with increasing investments in digital health platforms. Limited public funding remains a barrier, but partnerships and donor programs support implementation. Local providers are integrating modular, cost-effective solutions in mid-sized hospitals. It is gradually expanding as awareness and technical readiness improve.

Middle East

The Middle East Infection Surveillance Solutions Market size was valued at USD 18.86 million in 2018 to USD 27.16 million in 2024 and is anticipated to reach USD 67.70 million by 2032, at a CAGR of 12.2% during the forecast period. The region is witnessing rising interest in infection surveillance due to the expansion of smart hospitals and high-end medical centers. Countries like the UAE and Saudi Arabia are leading in digital healthcare adoption. Government initiatives aimed at infection reduction and clinical transparency support market growth. Demand for cloud-based and multilingual platforms is also rising. It is positioning itself as a growing healthcare technology hub.

Africa

The Africa Infection Surveillance Solutions Market size was valued at USD 15.32 million in 2018 to USD 28.22 million in 2024 and is anticipated to reach USD 69.75 million by 2032, at a CAGR of 11.7% during the forecast period. The region faces challenges related to limited infrastructure and funding but presents long-term opportunities. International health agencies are supporting electronic infection monitoring in hospitals across South Africa, Egypt, and Kenya. The market is gradually opening to web-based systems requiring minimal on-site IT resources. Awareness of infection prevention and data-driven health strategies is growing. It remains a developing market with high future potential.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Becton, Dickinson and Company
Cerner Corporation
Premier, Inc.
Baxter International Inc.
Wolters Kluwer N.V.
Merative
Ecolab
bioMérieux SA
Gojo Industries, Inc.
RLDatix
Wolters Kluwer Health
Epic Systems
Biovigil Healthcare Systems
Vecna Technologies
IBM Watson Health
Medexter Healthcare
CKM Healthcare Incorporated
PointClickCare
Stanley Healthcare

Competitive Analysis

The Infection Surveillance Solutions Market is characterized by the presence of several established and emerging players competing on technology, scalability, and service integration. Key companies such as Becton, Dickinson and Company, Cerner Corporation, and Wolters Kluwer offer comprehensive platforms with advanced analytics and real-time monitoring capabilities. These vendors focus on strategic partnerships, cloud integration, and AI-driven functionalities to enhance infection detection and reporting. New entrants are introducing modular, cost-effective solutions targeting mid-sized healthcare providers. Market players emphasize regulatory compliance, user-friendly design, and interoperability with electronic health records. It remains highly dynamic, driven by continuous innovation, mergers, and regional expansions. Competitive intensity is rising as providers demand scalable, secure, and customizable systems. Companies are also investing in customer support, training, and post-deployment services to strengthen client retention. The Infection Surveillance Solutions Market favors agile players that can align with healthcare digitization trends and evolving infection control requirements across diverse care settings.

Recent Developments

In 2024, Steris Corporation acquired surgical instrumentation assets from Becton Dickinson and Company for approximately USD 540 million and completed the acquisition of Key Surgical for USD 850 million, strengthening its infection surveillance and surgical solutions portfolio.
In May 2025, the Fiji Centre for Disease Control launched its first Pathogen Genomics Laboratory to bolster national surveillance capabilities for infectious diseases and antimicrobial resistance.
In July 2025, Seegene Inc. unveiled STAgora™, an AI-powered infectious disease analytics platform offering real-time PCR‑based diagnostics, predictive modeling, and outbreak tracking globally.

Market Concentration & Characteristics

The Infection Surveillance Solutions Market exhibits moderate to high market concentration, with a few dominant players such as Becton, Dickinson and Company, Cerner Corporation, and Wolters Kluwer holding significant global shares. It features a mix of global corporations and specialized software firms competing on innovation, regulatory compliance, and integration capabilities. Vendors prioritize AI-driven analytics, cloud-based platforms, and seamless interoperability with electronic health records to enhance user value. The market is characterized by long-term contracts, solution customization, and a focus on end-user support services. High entry barriers exist due to stringent healthcare regulations, data security requirements, and the need for deep clinical expertise. Buyers prioritize platforms that offer scalability, real-time monitoring, and actionable insights, driving continuous R&D investments. The Infection Surveillance Solutions Market also demonstrates a growing shift toward modular and subscription-based pricing models to improve affordability and access. It remains dynamic, innovation-driven, and closely aligned with global healthcare digitization trends.

Report Coverage

The research report offers an in-depth analysis based on Product and Service, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

Demand for AI-integrated surveillance systems will increase to support early infection detection and predictive risk assessment.
Cloud-based solutions will gain wider acceptance due to their scalability, ease of deployment, and cost-efficiency.
Healthcare providers will prioritize platforms that offer real-time data sharing and interoperability with existing hospital systems.
Adoption in long-term care facilities and ambulatory centers will rise with growing focus on post-acute infection control.
Vendors will invest in developing multilingual and region-specific solutions to expand into emerging markets.
Mobile-compatible platforms will become more prevalent to support remote monitoring and decentralized care models.
Governments will introduce stricter mandates on infection reporting, driving increased compliance-based technology adoption.
Strategic partnerships between tech firms and healthcare providers will foster innovation and rapid deployment.
Increased focus on antimicrobial resistance tracking will push demand for advanced analytics features.
End users will favor customizable, user-friendly interfaces to improve workflow efficiency and staff engagement.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : INFECTION SURVEILLANCE SOLUTIONS MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by product

CHAPTERNO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 End User Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product & Services & End User Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Infection Surveillance Solutions Market Import Revenue By Region

6.2. Export Analysis by Region

6.2.1. Global Infection Surveillance Solutions Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Infection Surveillance Solutions Market: Company Market Share

7.2. Global Infection Surveillance Solutions Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : INFECTION SURVEILLANCE SOLUTIONS MARKET – BY PRODUCT & SERVICES SEGMENT ANALYSIS

8.1. Infection Surveillance Solutions Market Overview by Product & Services Segment

8.1.1. Infection Surveillance Solutions Market Revenue Share By Product & Services

8.1.2. Infection Surveillance Solutions Market Revenue Share By Product & Services

8.2. Software

8.2.1 On-Premises Software

8.2.2 Web-Based Software

8.3. Services

8.3.1 Product Support & Maintenance Services

8.3.2 Training & Consulting Services

8.3.3 Implementation Services

CHAPTER NO. 9 : INFECTION SURVEILLANCE SOLUTIONS MARKET – BY END USER SEGMENT ANALYSIS

9.1. Infection Surveillance Solutions Market Overview by End User Segment

9.1.1. Infection Surveillance Solutions Market Revenue Share By End User

9.1.2. Infection Surveillance Solutions Market Revenue Share By End User

9.2. Hospitals

9.3. Long-Term Care Facilities

9.4. Other End Users

CHAPTER NO. 10 : INFECTION SURVEILLANCE SOLUTIONS MARKET – REGIONAL ANALYSIS

10.1. Infection Surveillance Solutions Market Overview by Region Segment

10.1.1. Global Infection Surveillance Solutions Market Revenue Share By Region

10.1.2. Regions

10.1.3. Global Infection Surveillance Solutions Market Revenue By Region

10.1.4. Global Infection Surveillance Solutions Market Revenue By Region

10.1.5. Product & Services

10.1.6. Global Infection Surveillance Solutions Market Revenue By Product & Services

10.1.7. Global Infection Surveillance Solutions Market Revenue By Product & Services

10.1.8. End User

10.1.9. Global Infection Surveillance Solutions Market Revenue By End User

10.1.10. Global Infection Surveillance Solutions Market Revenue By End User

CHAPTER NO. 11 : NORTH AMERICA Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

11.1. North America Infection Surveillance Solutions Market Overview by Country Segment

11.1.1. North America Infection Surveillance Solutions Market Revenue Share By Region

11.2. North America

11.2.1. North America Infection Surveillance Solutions Market Revenue By Country

11.2.2. Product & Services

11.2.3. North America Infection Surveillance Solutions Market Revenue By Product & Services

11.2.4. End User

11.2.5. North America Infection Surveillance Solutions Market Revenue By End User

11.3. U.S.

11.4. Canada

11.5. Mexico

CHAPTER NO. 12 : EUROPE Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

12.1. Europe Infection Surveillance Solutions Market Overview by Country Segment

12.1.1. Europe Infection Surveillance Solutions Market Revenue Share By Region

12.2. Europe

12.2.1. Europe Infection Surveillance Solutions Market Revenue By Country

12.2.2. Product & Services

12.2.3. Europe Infection Surveillance Solutions Market Revenue By Product & Services

12.2.4. End User

12.2.5. Europe Infection Surveillance Solutions Market Revenue By End User

12.3. UK

12.4. France

12.5. Germany

12.6. Italy

12.7. Spain

12.8. Russia

12.9. Rest of Europe

CHAPTER NO. 13 : ASIA PACIFIC Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

13.1. Asia Pacific Infection Surveillance Solutions Market Overview by Country Segment

13.1.1. Asia Pacific Infection Surveillance Solutions Market Revenue Share By Region

13.2. Asia Pacific

13.2.1. Asia Pacific Infection Surveillance Solutions Market Revenue By Country

13.2.2. Product & Services

13.2.3. Asia Pacific Infection Surveillance Solutions Market Revenue By Product & Services

13.2.4. End User

13.2.5. Asia Pacific Infection Surveillance Solutions Market Revenue By End User

13.3. China

13.4. Japan

13.5. South Korea

13.6. India

13.7. Australia

13.8. Southeast Asia

13.9. Rest of Asia Pacific

CHAPTER NO. 14 : LATIN AMERICA Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

14.1. Latin America Infection Surveillance Solutions Market Overview by Country Segment

14.1.1. Latin America Infection Surveillance Solutions Market Revenue Share By Region

14.2. Latin America

14.2.1. Latin America Infection Surveillance Solutions Market Revenue By Country

14.2.2. Product & Services

14.2.3. Latin America Infection Surveillance Solutions Market Revenue By Product & Services

14.2.4. End User

14.2.5. Latin America Infection Surveillance Solutions Market Revenue By End User

14.3. Brazil

14.4. Argentina

14.5. Rest of Latin America

CHAPTER NO. 15 : MIDDLE EAST Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

15.1. Middle East Infection Surveillance Solutions Market Overview by Country Segment

15.1.1. Middle East Infection Surveillance Solutions Market Revenue Share By Region

15.2. Middle East

15.2.1. Middle East Infection Surveillance Solutions Market Revenue By Country

15.2.2. Product & Services

15.2.3. Middle East Infection Surveillance Solutions Market Revenue By Product & Services

15.2.4. End User

15.2.5. Middle East Infection Surveillance Solutions Market Revenue By End User

15.3. GCC Countries

15.4. Israel

15.5. Turkey

15.6. Rest of Middle East

CHAPTER NO. 16 : AFRICA Infection Surveillance Solutions MARKET – COUNTRY ANALYSIS

16.1. Africa Infection Surveillance Solutions Market Overview by Country Segment

16.1.1. Africa Infection Surveillance Solutions Market Revenue Share By Region

16.2. Africa

16.2.1. Africa Infection Surveillance Solutions Market Revenue By Country

16.2.2. Product & Services

16.2.3. Africa Infection Surveillance Solutions Market Revenue By Product & Services

16.2.4. End User

16.2.5. Africa Infection Surveillance Solutions Market Revenue By End User

16.3. South Africa

16.4. Egypt

16.5. Rest of Africa

CHAPTER NO. 17 : COMPANY PROFILES

17.1. Becton, Dickinson and Company

17.1.1. Company Overview

17.1.2. Product Portfolio

17.1.3. Financial Overview

17.1.4. Recent Developments

17.1.5. Growth Strategy

17.1.6. SWOT Analysis

17.2. Cerner Corporation

17.3. Premier, Inc.

17.4. Baxter International Inc.

17.5. Wolters Kluwer N.V.

17.6. Merative

17.7. Ecolab

17.8 Biomerieux Sa

17.9 Gojo Industries, Inc.

17.10 Rldatix

17.11 Wolters Kluwer Health

17.12 Epic Systems

17.13. Premier Inc.

17.14 Biovigil Healthcare Systems

17.15 Vecna Technologies

17.16 IBM Watson Health

17.17 Medexter Healthcare

17.18 CKM Healthcare Incorporated

17.19 Pointclickcare

17.20 Stanley Healthcare

Frequently Asked Questions:

What is the current size of the Infection Surveillance Solutions Market?

The Infection Surveillance Solutions Market was valued at USD 703.66 million in 2024 and is projected to reach USD 1,928.54 million by 2032, driven by rapid adoption of real-time monitoring platforms in healthcare settings.

What are the key segments within the Infection Surveillance Solutions Market?

The market is segmented by product and services (software and services), including on-premises and web-based solutions, and by end users such as hospitals, long-term care facilities, and other healthcare providers.

What are some challenges faced by the Infection Surveillance Solutions Market?

Major challenges include high implementation costs, limited infrastructure in developing regions, technical complexity, and concerns over data privacy and regulatory compliance.

Who are the major players in the Infection Surveillance Solutions Market?

Leading players include Becton, Dickinson and Company, Cerner Corporation, Wolters Kluwer, Premier Inc., Baxter International, Merative, Ecolab, RLDatix, Epic Systems, and IBM Watson Health.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –